Delivery Order SPE2DB25D3110-SPE2DB25FTEMQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,143.32 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 10% Suspension in 100ML quantities, with a ceiling value of $2,985.58 and an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a $1,089.72 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procedures with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cipro 5% Suspension in 100mL quantities, with a ceiling value of $3,020.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension with a ceiling value of $1,227.35. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,624.01 to AmerisourceBergen Drug Corp for the supply of Cipro 5% Suspension in 100ml quantities. The contract, executed on September 24, 2025, with an ultimate completion date of September 25, 2025, carries firm fixed pricing and represents a competitively awarded non-set-aside transaction. Performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,967.88 delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed price contract represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,388.23 for Cipro 5% Suspension in 100ml quantities, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension in 100ml quantities, with a ceiling value of $1,332.60 under a firm fixed-price contract structure. This non-competitive delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEMQDelivery Order
The Defense Logistics Agency awarded a $4,205.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% suspension. This non-competitive, non-set-aside contract is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's broader federal contracting relationships. This award is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. The cipro suspension delivery aligns with the vendor's established portfolio supplying antibiotics and other critical pharmaceuticals to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/25/25 |